InvestorsObserver
×
News Home

Does Inhibrx Inc (INBX) Have What it Takes to be in Your Portfolio Thursday?

Thursday, August 18, 2022 12:55 PM | InvestorsObserver Analysts

Mentioned in this article

Does Inhibrx Inc (INBX) Have What it Takes to be in Your Portfolio Thursday?

A rating of 90 puts Inhibrx Inc (INBX) near the top of the Biotechnology industry according to InvestorsObserver. Inhibrx Inc's score of 90 means it scores higher than 90% of stocks in the industry. Inhibrx Inc also received an overall rating of 78, putting it above 78% of all stocks. Biotechnology is ranked 29 out of the 148 industries.

Overall Score - 78
INBX has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on INBX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Inhibrx Inc Stock Today?

Inhibrx Inc (INBX) stock is trading at $19.77 as of 12:53 PM on Thursday, Aug 18, a loss of -$2.43, or -10.95% from the previous closing price of $22.20. The stock has traded between $19.34 and $22.20 so far today. Volume today is light. So far 158,220 shares have traded compared to average volume of 369,072 shares. Click Here to get the full Stock Report for Inhibrx Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App